Healthcare and Medical/

Neuropathic Ocular Pain Market Set to Experience Significant Growth by 2030

Saya Bonde

Neuropathic Ocular Pain Market Set to Experience Significant Growth by 2030

Global Neuropathic Ocular Pain market is estimated to be valued at US$ 197.1 million in 2023 and is expected to exhibit a CAGR of 3.13% during the forecast period (2023-2030). Neuropathic pain is a pain condition that’s usually chronic. It’s usually caused by chronic, progressive nerve disease, and it can also occur as the result of injury or infection. Ocular neuropathic pain, also referred to as corneal neuropathic pain, is a condition where corneal pain is seen in response to normally non-painful stimuli. This results from repeated direct damage to corneal nerves.

Coherent Market Insights announces the publication of its most recently generated research report titled, “Neuropathic Ocular Pain Market – Forecast to 2030″, which offers a holistic view of the Neuropathic Ocular Pain market through systematic segmentation that covers every aspect of the target market. Neuropathic Ocular Pain with 100+ market data Tables, Pie Chat, Graphs and Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items. Neuropathic Ocular Pain Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry.

Click Here to Get a Sample Copy of the Report: https://www.coherentmarketinsights.com/insight/request-sample/5600

Market Overview:

This all-encompassing study was created in collaboration with core business professionals, as well as a specialized assessment inspection group, to lend Neuropathic Ocular Pain market report a comprehensive representation of current market conditions, enabling its intended owner to make critical business decisions with confidence. The Neuropathic Ocular Pain market objective of this detailed guide is to assist our valued customers to develop plans that will re-calibrate existing business practices, allowing them to reach previously unattainable business success. This comprehensive analysis will include information on prospective mergers & acquisitions, as well as revenues recorded by various Neuropathic Ocular Pain market players. A thorough study of this industry’s segmentation will help lead to a better comprehension of the various elements that influence Neuropathic Ocular Pain market.

Competitive Analysis:

The Neuropathic Ocular Pain market will include a thorough examination of this industry’s competitors, their respective company overviews and description, an analysis of their product portfolios, financials, etc. We even include supply-chain analysis, a PEST analysis, market probability scenarios, Porter’s Five Forces analysis, and even various market expansion strategies. This information will enable our clients to utilize this essential data and enable them to make the most-suitable business decisions that will improve their company’s footprint in this industry.

By Top Companies: OKYO Pharma, Limited, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, SALVAT, AbbVie Inc., Bausch & Lomb Incorporated, Kala Pharmaceuticals, Spectra Vision Care, Alcon Laboratories, AERIE PHARMACEUTICALS, INC., Optocred Pharmaceuticals and BRIM Biotechnology, Inc.

Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/5600

Features of the Neuropathic Ocular Pain Market Report

⮞In-depth Neuropathic Ocular Pain industry data presented in an easy-to-understand format

⮞Clear-cut market segmentation of the Neuropathic Ocular Pain industry, detailing key aspects of each sub-segment

⮞Well-analysed key market player profiles along with their corresponding strategies

⮞The precise analysis of potential regional and country-wise sales opportunities

⮞In-depth Intel concerning existing as well as potential trends in the Neuropathic Ocular Pain market

⮞Industry drivers and restraints of the Neuropathic Ocular Pain market have the potential to influence each of its segments and regions of operation.

⮞A precise comprehension of expansion strategies, new product launches, as well as potential acquisitions for various engaged companies.

⮞This report offers an amalgam of well-articulated literature, along with graphical representations of numerous related market variables.

The Major Points Covered in the Table of Contents:

Overview: This part provides a summary of the report, as well as a broad overview of the Neuropathic Ocular Pain Market, to offer an understanding of the nature and contents of the research study.

Market Analysis: The research forecasts the market share of key segments of the Neuropathic Ocular Pain Market with accuracy and reliability. This study may be used by industry participants to make strategic investments in key growth areas of the Neuropathic Ocular Pain Market.

Analysis of Leading Players’ Strategies: This report can be used by market participants to acquire a competitive advantage over their rivals in the Neuropathic Ocular Pain Market.

Regional Growth Analysis: The report covers all of the key areas and countries. The regional analysis will assist market players in tapping into untapped regional markets, developing unique regional strategies, and comparing the growth of all regional markets.

Market Forecasts: Report purchasers will get access to precise and validated estimations of the entire market size in terms of both value and volume. The study also includes estimates for the Neuropathic Ocular Pain Market in terms of consumption, production, sales, and other factors.

Contact Us:

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

Phone:

US: +1-206-701-6702

UK: +44-020-8133-4027

Japan: +81-050-5539-1737

India: +91-848-285-0837

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Follow Us: LinkedIn | Twitter

Saya Bonde

Neuropathic Ocular Pain Market Estimated to Witness High Growth Owing to Growing Research Initiatives into Novel Drug Therapies

ashwinicmi 2024-08-20

The Global Neuropathic Ocular Pain Market is estimated to be valued at US$ 209. Key TakeawaysKey players operating in the Neuropathic ocular pain are OKYO Pharma, Limited, Ocular Therapeutix, Inc. Globally, increasing prevalence of ocular diseases accompanied by neuropathic pain like herpes and post-herpetic neuralgia is expected to drive the expansion of neuropathic ocular pain market. Technological: Advancements in drug delivery systems and novel mechanisms of action are expanding treatment options for neuropathic ocular pain. The North American region currently accounts for the largest share of the global neuropathic ocular pain market in terms of value.

Neuropathic Ocular Pain Market Strategies: Elevating Ophthalmic Solutions

Roger 2023-12-14

The global Neuropathic Ocular Pain Market is estimated to be valued at US$ 197. Segment AnalysisThe global neuropathic ocular pain market is segmented based on product type, indication, distribution channel, and geography. Key TakeawaysThe global neuropathic ocular pain market is expected to witness high growth, exhibiting a CAGR of 3. Key playersKey players operating in the neuropathic ocular pain market are OKYO Pharma, Limited, Ocular Therapeutix, Inc. OKYO Pharma is dominating the market with its product PXT-864 which showed positive results in reducing neuropathic ocular pain in clinical trials.

Neuropathic Ocular Pain Market is projected to Increase Revenues Growth, Business Insights, Future Demand, and Forecast 2023-2030

Saya Bonde 2023-06-08

Your business will grow much faster with the help of an authentic source of statistical surveying from the Neuropathic Ocular Pain Market Report. 1 million in 2023 and is expected to exhibit a CAGR of 3. By identifying and examining market segments and forecasting global market size, the study also contributes to understanding the dynamics and structure of the global Neuropathic Ocular Pain market. The global Neuropathic Ocular Pain market is segmented on the basis of application, type, distribution channel, and geography. What are the prominent factors driving the Neuropathic Ocular Pain Market across different regions?

Global Neuropathic Pain Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

saikiran TBRC 2024-04-02

Sizing and ForecastThe neuropathic pain market size has grown strongly in recent years. The growth in the forecast period can be attributed to growing awareness of neuropathic pain, aging population, well-proliferated healthcare sector, accessibility to neuropathic pain treatments. The regions covered in neuropathic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. Therefore, the growing prevalence of chronic pain is driving the growth of the neuropathic pain market going forward. The neuropathic pain market report table of contents includes:1.

Neuropathic Pain Market Focusing Share, Future Trends, Opportunities including Forecast till 2027

Pooja salve 2023-03-16

The Neuropathic Pain Market is fiercely competitive, with one main player concentrating on raising public awareness of the neuropathic pain sector. The Neuropathic Pain Market leading players have employed a variety of development methods, including product innovation, new launches and approvals, and investment in R&D for improvements. A, Abbott Laboratories, AstraZeneca, Johnson & Johnson Services Inc. The term "Neuropathic Pain" refers to pain brought on by a condition that affects the somatosensory nerve system. The most common cause of Neuropathic Pain, a complex and persistent pain condition, is injury to the tissues.

Neuropathic Pain Market Growth, Sales Revenue, Competitive Landscape and Market Expansion Strategies 2027

Tanmay 2022-05-17

This, in turn, is prognosticated to catalyze the expansion of the global neuropathic pain market growth over the assessment period. The development of pain management centers is another major factor responsible for the proliferation of the neuropathic pain market through the projection period. By diagnosis, the global neuropathic pain market growth has been segmented into imaging, blood tests, and physical examination. The revamping of the healthcare sector in the region is projected to augment the neuropathic pain market in the foreseeable future. About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

WHO TO FOLLOW

MORE FROM AUTHOR

Botulinum Toxin Market is Estimated to Witness High Growth Owing to Rising Demand for Anti-Wrinkle Treatment

Saya Bonde 2024-06-19

Rising Demand for Minimally Invasive Surgeries Drives Catheters Market Growth

Saya Bonde 2024-06-13

The Cell Culture Market is driven by increasing research and development activities in the pharmaceutical industry

Saya Bonde 2024-06-12

Microkeratome: The Blade for Safe and Effective LASIK Surgery

Saya Bonde 2024-06-06

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Neuropathic Pain Market 2020 Company Profiles, Trends, Industry Growth and Demand

Ashish Mandar 2020-10-07

This report on the Global Neuropathic Pain Market provides a global 360-degree perspective of the industry while taking into consideration historical data as well as providing accurate estimations of the future scope of the market.

This make it easier for the stakeholders of the report to utilize this information and incorporate changes in their business policies and be well informed about the market dynamics.

It also provides an insight into the competitive landscape of the market highlighting key competitors, major manufacturers dominating the Neuropathic Pain Market, while also providing an analysis of the market share and revenue generation figures.Ask for report free sample with complete TOC and list of tables/figures @ https://www.datalibraryresearch.com/sample-request/neuropathic-pain-market-2178Global Neuropathic Pain Market Competitive Analysis:Eli Lilly and CompanyAstellas Pharma Inc.Biogen Inc.Baxter Healthcare CorporationPfizer, Inc.Sanofi S.AAbbott LaboratoriesAstraZenecaJohnson & Johnson Services Inc.GlaxoSmithKline Plc.

Additionally, the report also calls out regions that have showed maximum growth in the past as well as regions that emerged as leaders of the market in historic years.

It utilizes this information to make predictions for regions which are expected to show rapid market growth, backing the predictions with solid analysis reasons.

Moreover, the report also lists out regions that are expected to show maximum potential for market growth in the years to come.

Neuropathic Pain Market Forecast Statistics, Trends, Segmentation Analysis 2022

Vaibhav W 2022-03-31

In addition, rising pipeline drugs by the companies for neuropathic pain is one of the major factors contributing to the growth of neuropathic pain. The Western Europe Neuropathic Pain Market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The major players of these countries are involved in new product launches and acquisitions for the Neuropathic Pain Market. The global Neuropathic Pain Market Forecast on the basis of diagnosis is segmented into physical examination, imaging, and blood tests. About Market Research FutureAt Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Neuralgia Treatment Market Overview | POST COVID-19 Impact| Top Players – PixarBio Corporation, Merz Pharma GmbH.

ava smith 2021-05-27

"Trending News:Neuralgia Treatment Market Report is Booming Globally by Top Leading Players"The global neuralgia treatment market size is predicted to reach USD 2.83 billion by 2027 according to a new study by Polaris Market Research.

The report “Neuralgia Treatment Market Size, Share & Trends Analysis Report, By Treatment (Drug Based [Anticonvulsant Medicines, Tricyclic Antidepressants], Surgeries [Balloon Compression, Glycerol Injection, Radiofrequency Thermal Lesioning, Stereotactic Radiosurgery, Microvascular Decompression]); By End-Use; By Region, And Segment Forecasts, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neuralgia treatment market is expected to witness significant growth owing to the increasing incidences of diabetes and trigeminal neuralgia.

Multiple sclerosis decreases the body immunity owing to the neurodegenerative condition which affects the myelin sheath that can cause neuralgia.

This is likely to drive market demand over the forecast period.GET SAMPLE PDF:- https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment-market/request-for-sampleThe potential drug candidates and the expected drug approval is expected to stimulate the global market, with high concentration of pharmaceutical companies engaged in the research & development of novel drugs for neuralgia treatment.

For instance, U.S-based drug manufacturer, Biogen Inc. is developing BIIB074 (Vixotrigine) for the treatment of trigeminal neuralgia and is currently in phase II.

Neuropathic Ocular Pain: A Closer Look at an Under-Recognized Condition

Dhritiman 2024-10-31

Causes There are several potential causes of neuropathic ocular pain, with the most common being trigeminal nerve damage or injury. - Herpes Zoster Ophthalmicus: Shingles that affects the ophthalmic division of the trigeminal nerve can lead to postherpetic neuralgia and chronic ocular pain. - Multiple Sclerosis: Inflammation and demyelination of nerve fibers associated with MS sometimes affects trigeminal nerve function resulting in eye pain. Clinical Presentation neuropathic ocular pain presents with a variety of symptoms that originate from trigeminal nerve areas. The symptoms of neuropathic ocular pain tend to be constant or recurrent in nature.

Global U.S. Neuropathic Pain Treatment Market : Advancements Fueling Growth and Improving Patient Outcomes

Gauri Cmi 2023-09-06

The demand for neuropathic pain treatments is driven by the rising incidence of nerve-related disorders, such as diabetic neuropathy, postherpetic neuralgia, and trigeminal neuralgia. For example, genetic testing can identify specific genes associated with neuropathic pain, allowing clinicians to prescribe medications that are most likely to be effective for each patient. However, the chronic nature of neuropathic pain often leads patients to prioritize the effectiveness of treatment over price, reducing their bargaining power. Threat of New Substitutes: Low The threat of new substitutes is low as neuropathic pain treatments are specialized and cater to specific patient needs. As key players continue to invest in research and development, patient outcomes are expected to improve, leading to a better quality of life for individuals living with neuropathic pain.

Neuropathic Pain Market: Global Industry Analysis, Size, Sales and Forecast By 2026

harsh143 kumar 2018-09-11

North America will continue to be the Leading Market for Neuropathic Pain over the Forecast Period (2016–2024)

According to a recent study conducted by RRI, the global market for neuropathic pain is expected to reflect a CAGR of over 5% during the forecast period (2016–2024). In 2015, the market was valued at over US$ 5 Billion and is estimated to stand at US$ 8.3 Billion by 2024 end.

Report For Report Sample with Table of Contents@https://www.researchreportinsights.com/report/sample/110114956/Neuropathic-Pain-Market

Factors such as increasing prevalence of chronic disorders including cancer and diabetes, introduction of newer modalities of receiving neuropathic pain treatment, growing number of pain management service providers and higher demand for neuropathic pain treatment drugs are expected to support the growth of neuropathic pain market globally. Further, arrival of various new medications for neuropathic pain treatment in the market, increasing patient awareness on the availability of advanced neuropathic pain therapeutics and rising demand for generic drugs are additional factors expected to drive the market growth. Moreover, pharmaceutical companies are actively focusing on developing enhanced drugs to cater to the requirement of patients with neuropathic disorders. In contrast to all of that, adverse side effects of steroids and opioids coupled with high cost of branded drugs may act as impediments for the global market of neuropathic pain.

Based on drug class, the global market for neuropathic pain has been segmented into anticonvulsants, tricyclic antidepressant, opioids, local anaesthesia, steroids, and others. Anticonvulsants drug is anticipated to be the largest segment of the market, reflecting a CAGR of over 6% during the forecast period. Minimum risk of side effects is a major factor driving the demand for this segment. By the end of 2024, the segment is estimated surpass market valuation of over US$ 3 Billion. Tricyclic antidepressant drugs are also gaining popularity amongst the physicians and patients and the segment is expected to witness a sound growth during the forecast period.

By indication, the market has been segmented into chemotherapy induced peripheral neuropathy, diabetic neuropathy, and others. Diabetic Neuropathy segment accounts for the largest share of the market. By the end of 2016, the segment is anticipated to account for nearly 47% share of the market in terms of value. On the other hand, chemotherapy induced peripheral neuropathy indication is projected to account for over 42% share of the market in revenue by 2016 end.

Request For Report Discount@https://www.researchreportinsights.com/report/discount/110114956/Neuropathic-Pain-Market

By region, the global market for neuropathic pain has been segmented into Asia Pacific North America, Europe, Latin America and the Middle East & Africa. North America is anticipated to be the most lucrative market for neuropathic pain, account highest share of the market in terms of value. The market in the region is expected to expand at a CAGR of over 5% during the forecast period. This is primarily due to a strong distribution network and presence of advanced healthcare infrastructure and major players of the market in the region.

Vendor News
Key players operating in the global market for neuropathic pain include Bristol Myers Squibb, Depomed, Inc., GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., Eli Lily and Company, Baxter Healthcare Corporation, Biogen Idec, and Johnson & Johnson Services, Inc. Most of these pharmaceutical companies are actively focusing on developing enhanced medication for treat neuropathic pain and other disorders in order to strengthen their presence in the global market for neuropathic pain.

Summary: Global market for neuropathic pain is expected to surpass market valuation of US$ 8 Billion by the end of 2024

Report Analysis@https://www.researchreportinsights.com/report/rd/110114956/Neuropathic-Pain-Market

U.S. Neuropathic Pain Treatment Market is Estimated to Witness High Growth

Sneha 2024-01-24

like diabetic neuropathy, postherpetic neuralgia, chemotherapy-induced neuropathy, trauma-related neuropathic pain, etc. provides a huge market opportunity for neuropathic pain treatment drugs. As per estimates, over100 million Americans suffer from chronic pain daily out of which 20-25 million people experience neuropathic pain. Hence, the growing neuropathic patient pool suffering due to the high burden of neuropathic disorders necessitates effective neuropathic pain management, creating lucrative growth opportunities for players in the U. Competitive rivalry: The US neuropathic pain market has the presence of global pharmaceutical giants and mid-sized companies.

NONSURGICAL TREATMENT OPTIONS

Myspine MD 2019-09-23

Back Pain Specialist FortWorth, Dr Anil Kesani Spine Surgeon-MySpineMDPhysical therapy is a valuable treatment option in treating patients with spine problems such as neck pain, back pain, cervical strains, lumbar sprains as well as degenerative disease related pain symptoms.Oral MedicationsMedications such as nonsteroidal antiinflammatories (NSAIDS), Gabapentin (Neurontin) and Pregabalin (Lyrica) can be very effective in helping with inflammatory as well as neuropathic pain associated in patients with spine problems.

Long term use of narcotic pain medications are best avoided to prevent dependence and overdose issues.

Frequently, long term use of narcotics can be avoided by accurate diagnosis and rapid treatment of spine problems.

However, in certain circumstances a short course of narcotic pain medications maybe appropriate such as in the control of surgical pain and acute severe pain symptoms related to spinal problems.Chiropractic TreatmentIn certain circumstances patients benefit greatly from chiropractic treatment.

Generally speaking if there is no spinal instability, severe spinal cord or nerve root impingement then it should be safe for patients to undergo chiropractic treatment.

If however, you are concerned about potential spinal instability or severe spinal cord/nerve root compression we would be happy to evaluate your condition further.

Neuropathic Pain Market Demand, Share And Forecast Analysis 2027

Supriya kokate 2021-01-29

The Global Neuropathic Pain Market research report offers accurate insights for the growth prospects of the Neuropathic Pain market in the forecast years 2020-2027.

The report is an all-inclusive study of the Neuropathic Pain market that offers the readers a better view of the current and emerging market trends through a thorough analysis of the market size, growth trends, supply and demand ratio, market share, sales network and distribution channels, and other key elements.Furthermore, the report is furnished with the current market scenario with regards to the COVID-19 pandemic.

The global public health emergency has disrupted the lives of everyone across the globe.

It has also had a substantial impact on the Neuropathic Pain industry as global supply chains have been disrupted, and the financial scenario is tight.

The report assesses the initial and future impact of the pandemic on the market and its key segments to offer an accurate futuristic outlook for remuneration in a post-COVID-19 scenario.Get a sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/3603Scope of the Market Report: The report offers a holistic overview of the Neuropathic Pain industry that offers all the essential information.

Along with this, the report extensively studies the competitive landscape in the market and profiles the key players of the industry.The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies.

A Nerve for Change: Exploring Trends in the Neuropathic Pain Market

sam saindane 2023-10-27

Moreover, increase in demand for neuropathic pain market drugs and introduction of latest products for the treatment of neuropathic pain boost the growth of the market. , Canada, Mexico) Europe (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA) Competitive Landscape: Astellas Pharma Inc. com/request-for-customization/5447 For Purchase Enquiry: https://www. com/purchase-enquiry/5447 Key Points Covered by the Report - What are the fundamental skills, core competencies, and key players in the industry we are examining? com Follow Us on: LinkedIn Twitter

Revolutionizing Your Medical Practice With Online Pain Doctors And Telemedicines

Youssef Pain Management 2022-08-30

Online Pain Doctors is not a new concept. However, today there are many new tools in a healthcare practitioner's arsenal to help chronic pain patients seek consistent, high-quality care and treatment. The Internet provides a virtual infrastructure platform that will facilitate the diagnosis, treatment and management of chronic pain for years to come. Be sure to ask about telemedicine pain management services and options offered by your online pain doctors. To learn more, visit us at Youssef Pain Management!

Neuropathic Pain Market Predicted to Witness Surge in The Near Future

Devanand Patil 2021-08-06

Global Neuropathic Pain Market: OverviewNeuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system.

Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=19871 This report on global neuropathic pain market is a thorough study of the market in its current scenario and based on all the major factors that may impact the growth rate in the near future, it estimates the state of the market until 2024.

By distribution channel, the market can be segmented into retail pharmacies, drug stores, and online pharmacies.

Geographically, the report studies the opportunities available in the regions of Asia Pacific, Europe, North America, and Rest of the World.

According to the World Health Organization (WHO), 422 million people were suffering from diabetes in 2014 and this number will continue to expand in the near future, especially among the middle to low-income countries.

In addition to that, factors such as approval of novel treatment options, increasing demand for neuropathic pain, improving healthcare infrastructure in emerging economies, increased investment by pharmaceutical companies for research and development of improved drugs, and rising number of pain management centers will further fuel the market in positive direction.

Neuropathic Pain Treatment Methods

USA INFO LIVE 2023-01-25

The pain signal is muddled in the brains of those suffering from neuropathic pain. Infections, tumors, vascular malformations, alcoholism, neurological conditions such as multiple sclerosis, and metabolic diseases such as diabetes are all common causes of neuropathic pain. Patients suffering from chronic neuropathic pain may benefit from referral to a pain clinic. Opioids, on the other hand, have not always demonstrated promise in the treatment of a variety of severe conditions, including neuropathic pain. People Suffering from Neuropathic Pain Can Receive AssistancePain has different effects on different people depending on its severity, location, duration, and frequency.

Ocular Implant Market is Estimated to Witness High Growth Owing to Rising Incidence of Eye Diseases

Omkar Patel 2024-02-01

Newer generation ocular implants offer more biocompatibility, reduced risk of infections and improve visual acuity compared to traditional implants. Rising prevalence of ocular disorders and diseases is a major driver for the Ocular Implant MarketThe prevalence of various ocular disorders and diseases has been increasing significantly across the globe. Ageing population represents a major opportunity Population ageing is a significant global demographic trend, with the number of people aged 65 years and above projected to double from 703 million currently to 1. This large and growing aged base translates to a substantial patient pool needing ocular implant procedures in the coming years. Increasing adoption of minimally invasive implantation techniquesA prominent trend in the ocular implant market has been the rising adoption of minimally invasive surgical techniques over conventional procedures.